Best Practices and Research Advances in Thoracic Oncology: A Regional Series LATAM Course 1: Liquid Biopsy in Lung Cancer-A Practical Case to Open Debate

Video Transcription

Video Summary

In the webinar presented by Valeria Denijo, liquid biopsy and its applications in detecting mutations in non-small cell lung cancer were discussed. The COVAX-HFER mutation test, noted for its quick turnaround and affordability, is highlighted as an essential tool in such diagnostics, especially vital for low-income regions. The webinar featured a retrospective study conducted in Argentina and Uruguay, examining mutation detection rates and patient outcomes using first and second-generation tyrosine kinase inhibitors. Challenges in bioinformatics, particularly with Next-Generation Sequencing (NGS), were also addressed, emphasizing the importance of robust informatics for reliable results.

Asset Subtitle

Valeria Denninghoff, PhD

Keywords

liquid biopsy

non-small cell lung cancer

COVAX-HFER mutation test

Next-Generation Sequencing

tyrosine kinase inhibitors